Thermogenesis Holdings Inc
NASDAQ:THMO
Thermogenesis Holdings Inc
Revenue
Thermogenesis Holdings Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Thermogenesis Holdings Inc
NASDAQ:THMO
|
Revenue
$9.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-6%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Thermogenesis Holdings Inc
Revenue Breakdown
Breakdown by Geography
Thermogenesis Holdings Inc
Breakdown by Segments
Thermogenesis Holdings Inc
Total Revenue:
9.4m
USD
|
Device Revenue:
6.9m
USD
|
Service:
1.8m
USD
|
Exclusivity Fee:
781k
USD
|
Clinical Revenue:
135k
USD
|
See Also
What is Thermogenesis Holdings Inc's Revenue?
Revenue
9.4m
USD
Based on the financial report for Dec 31, 2023, Thermogenesis Holdings Inc's Revenue amounts to 9.4m USD.
What is Thermogenesis Holdings Inc's Revenue growth rate?
Revenue CAGR 10Y
-6%
Over the last year, the Revenue growth was -10%. The average annual Revenue growth rates for Thermogenesis Holdings Inc have been -1% over the past three years , and -6% over the past ten years .